Tributary Capital Management LLC Buys 3,116 Shares of Molina Healthcare, Inc $MOH

Tributary Capital Management LLC grew its stake in shares of Molina Healthcare, Inc (NYSE:MOH) by 107.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,026 shares of the company’s stock after purchasing an additional 3,116 shares during the period. Tributary Capital Management LLC’s holdings in Molina Healthcare were worth $1,153,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Baird Financial Group Inc. acquired a new position in Molina Healthcare during the 1st quarter worth approximately $210,000. NewEdge Advisors LLC grew its stake in Molina Healthcare by 33.4% in the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock valued at $364,000 after acquiring an additional 277 shares during the period. Jones Financial Companies Lllp grew its stake in Molina Healthcare by 713.3% in the first quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock valued at $544,000 after acquiring an additional 1,448 shares during the period. Goldman Sachs Group Inc. increased its holdings in shares of Molina Healthcare by 19.4% during the first quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock valued at $82,172,000 after acquiring an additional 40,531 shares in the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. raised its position in shares of Molina Healthcare by 18.5% during the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 1,031 shares of the company’s stock worth $340,000 after purchasing an additional 161 shares during the period. Institutional investors own 98.50% of the company’s stock.

Insider Activity

In other news, Director Richard M. Schapiro sold 357 shares of Molina Healthcare stock in a transaction on Monday, November 24th. The stock was sold at an average price of $143.02, for a total transaction of $51,058.14. Following the sale, the director directly owned 11,352 shares in the company, valued at $1,623,563.04. The trade was a 3.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.10% of the stock is currently owned by corporate insiders.

Molina Healthcare Price Performance

Molina Healthcare stock opened at $176.27 on Thursday. Molina Healthcare, Inc has a 52 week low of $133.40 and a 52 week high of $359.97. The company’s 50 day moving average price is $155.56 and its two-hundred day moving average price is $179.68. The stock has a market cap of $9.55 billion, a P/E ratio of 10.91 and a beta of 0.49. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.92.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 EPS for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). The business had revenue of $11.48 billion for the quarter, compared to analysts’ expectations of $10.99 billion. Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The business’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business posted $6.01 earnings per share. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. On average, equities analysts predict that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. TD Cowen cut Molina Healthcare from a “buy” rating to a “hold” rating and set a $203.00 target price on the stock. in a report on Thursday, October 16th. Sanford C. Bernstein reiterated an “outperform” rating and set a $224.00 price objective on shares of Molina Healthcare in a report on Tuesday. Weiss Ratings reissued a “sell (d+)” rating on shares of Molina Healthcare in a research report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $165.00 price target on shares of Molina Healthcare in a research report on Friday, October 24th. Finally, Cantor Fitzgerald decreased their price objective on Molina Healthcare from $210.00 to $180.00 and set a “neutral” rating for the company in a report on Friday, October 24th. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $200.80.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.